[
    [
        {
            "time": "2023-10-01",
            "original_text": "These 5 Prescription Drugs Will Generate a Jaw-Dropping $62.3 Billion in 2024",
            "features": {
                "keywords": [
                    "Prescription Drugs",
                    "Generate",
                    "Jaw-Dropping",
                    "$62.3 Billion"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "These 5 Prescription Drugs Will Generate a Jaw-Dropping $62.3 Billion in 2024",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 10,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "Notable Insider Buys: AbbVie, Bristol-Myers And More",
            "features": {
                "keywords": [
                    "Notable Insider Buys",
                    "AbbVie",
                    "Bristol-Myers"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Notable Insider Buys: AbbVie, Bristol-Myers And More",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]